TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05290363: The Role of IL-23 in Chronic Inflammatory Disease: Exploring the Cellular and Molecular Targets of IL-23 Signaling in Peripheral and Axial Spondyloarthritis

Sponsor: Institut Pasteur · Phase: PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 90 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$3,898,500

Rescue Site Savings

+$2,587,500

Unlock Full NCT05290363 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05290363 Rescue Dossier →